CCEP's Volume Growth Narrative Faces Its First Test Without Calendar Tailwinds

Coca-Cola Europacific Partners Plc (CCEP) reports earnings on June 16, 2026, with investors focused on whether the company can sustain its strong start to the year amid a challenging consumer environment. The release comes as CCEP navigates pricing pressures, volume growth dynamics across Europe and Asia-Pacific, and ongoing investments in capacity expansion—all while maintaining its track record of consistent execution and shareholder returns.

Part 1: Earnings Preview

Coca-Cola Europacific Partners is one of the world's largest independent Coca-Cola bottlers, producing and distributing a broad portfolio of non-alcoholic beverages across Europe and the Asia-Pacific region. The company serves as a critical link between The Coca-Cola Company's brands and consumers in key markets including Great Britain, France, Germany, Spain, and Australia.

CCEP is scheduled to report earnings on June 16, 2026. The company most recently reported earnings for Q4 2025 in February 2026, delivering $1.35 EPS—a significant beat that exceeded expectations by 48.35%. For the full year 2026, analysts expect $5.00 EPS (based on 4 estimates ranging from $4.44 to $5.27), representing +7.53% growth year-over-year. For 2027, the consensus stands at $5.50 EPS with +10.00% growth expected.

Three key themes define this earnings story:

Volume Growth vs. Pricing Balance: CCEP delivered 8.5% comparable volume growth in Q1 2026, with revenue up 9.4% to €5 billion. The critical question is whether the company can maintain this momentum while managing the ongoing consumer demand for value. CEO Damian Gammell noted that "the consumer environment remains challenging," but the company continues to deliver "solid comparable volume growth and share gains driven by great execution." Investors will watch closely to see if CCEP can sustain balanced topline delivery without sacrificing pricing power.

Geographic Performance Divergence: Europe showed stronger momentum with 9.8% revenue growth and 8.4% volume growth in Q1, while Asia-Pacific (APS) delivered more modest gains of 8.6% revenue growth but slightly negative comparable volume growth of -0.3%. The disparity raises questions about whether APS headwinds—including uncertainty from the Middle East situation—will weigh on overall results, or whether Europe's strength can offset regional challenges.

Investment Cycle and Margin Trajectory: CCEP is "investing more than ever in growth, from technology and AI, to more coolers and our new plant in the Philippines," according to management. With Q4 2024 operating margin at 11.6% and Q1 2026 revenue per unit case up just 0.8%, investors will scrutinize whether heavy capital deployment is pressuring near-term profitability, or if the company can demonstrate operating leverage as volumes scale.

Analyst commentary ahead of the release has been constructive. UBS recently raised its price target to $109 from $107 while maintaining a Buy rating, reflecting confidence in CCEP's execution. The consensus among 15 analysts shows 10 Strong Buys, 4 Holds, and 1 Strong Sell, with an average price target of $107.45—implying meaningful upside from current levels. Analysts appear focused on CCEP's ability to navigate the challenging consumer backdrop while delivering on its mid-term objectives of sustained volume growth, margin expansion, and shareholder returns through dividends and buybacks.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of ±0.62% (or $0.61) through the June 18 expiration, with the stock anticipated to trade between $98.89 and $100.11. Without historical earnings move data available for comparison, this expected move provides the primary quantitative framework for gauging post-earnings volatility expectations heading into the release.

Part 3: What Analysts Are Saying

Analyst sentiment on CCEP is decidedly bullish heading into earnings. The consensus rating stands at 4.20 out of 5.0—firmly in Buy territory—with an average price target of $107.45. This implies approximately 8% upside from the current price of $99.41.

The rating breakdown shows strong conviction: 10 analysts rate CCEP a Strong Buy, while 4 maintain Hold ratings and just 1 has a Strong Sell. Price target estimates range from a low of $81.00 to a high of $118.00, reflecting a wide spectrum of views but with the consensus clustering well above current levels.

Sentiment has improved over the past month, with Strong Buy ratings increasing from 9 to 10 and the average recommendation ticking up from 4.14 to 4.20. This positive shift suggests analysts are gaining confidence in CCEP's execution and growth trajectory as the company navigates the challenging consumer environment while investing heavily in capacity and technology. The improving sentiment aligns with recent price target increases, including UBS's April upgrade to $109, and reflects growing optimism that CCEP can deliver on its mid-term objectives of sustained volume growth and margin expansion.

Part 4: Technical Picture

CCEP enters earnings with strong technical momentum. The Barchart Technical Opinion currently shows a 56% Buy signal, a significant improvement from the 24% Sell signal registered a month ago and up from the 8% Buy signal just last week. This rapid strengthening reflects accelerating bullish momentum as the stock has rallied into the earnings release.

Timeframe Analysis:

• Short-term (Hold): Neutral reading suggests some near-term consolidation or indecision despite the recent rally
• Medium-term (50% Buy): Moderate buy signal indicates positive momentum building in the intermediate timeframe
• Long-term (100% Buy): Strong buy signal confirms the longer-term uptrend remains firmly intact

Trend Characteristics: The trend is characterized as Soft but Strengthening, suggesting momentum is building but has not yet reached full conviction—a setup that could see acceleration on positive earnings news or vulnerability on disappointment.

The stock is trading above all major moving averages, a bullish configuration that underscores technical strength. CCEP sits above its 5-day MA ($98.16), 10-day MA ($95.62), 20-day MA ($94.14), 50-day MA ($94.70), 100-day MA ($96.31), and 200-day MA ($93.06). The ascending order of these moving averages—with shorter-term averages above longer-term ones—confirms an established uptrend with improving momentum.

At $99.41, CCEP is testing the psychological $100 level heading into earnings, with the next resistance zone likely near the $107-$108 area implied by analyst price targets. Support appears well-established in the $94-$96 range where multiple moving averages converge. The overall technical setup is supportive for earnings, with the stock in a clear uptrend, above all key moving averages, and showing strengthening momentum. However, the "Soft" trend strength designation suggests the rally could be vulnerable to profit-taking on any disappointment, while a strong beat could provide the catalyst to break decisively above $100 and target the analyst consensus price target zone.